Avita Medical Ltd (NASDAQ:RCEL) — Market Cap & Net Worth
Market Cap & Net Worth: Avita Medical Ltd (RCEL)
Avita Medical Ltd (NASDAQ:RCEL) has a market capitalization of $126.49 Million ($126.49 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18242 globally and #4226 in its home market, demonstrating a -4.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Avita Medical Ltd's stock price $4.40 by its total outstanding shares 30776689 (30.78 Million). See Avita Medical Ltd (RCEL) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Avita Medical Ltd Market Cap History: 2015 to 2026
Avita Medical Ltd's market capitalization history from 2015 to 2026. Data shows change from $227.75 Million to $135.42 Million (-6.27% CAGR).
Index Memberships
Avita Medical Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.01% | #517 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1786 of 3165 |
Weight: Avita Medical Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Avita Medical Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Avita Medical Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.48x
Avita Medical Ltd's market cap is 1.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $283.15 Million | $1.18 Million | -$11.51 Million | 239.83x | N/A |
| 2017 | $164.66 Million | $1.26 Million | -$17.21 Million | 131.18x | N/A |
| 2019 | $1.40 Billion | $5.40 Million | -$24.62 Million | 259.50x | N/A |
| 2020 | $571.83 Million | $5.40 Million | -$24.62 Million | 105.97x | N/A |
| 2021 | $368.70 Million | $33.02 Million | -$25.14 Million | 11.16x | N/A |
| 2022 | $203.13 Million | $34.42 Million | -$26.66 Million | 5.90x | N/A |
| 2023 | $422.26 Million | $50.14 Million | -$35.38 Million | 8.42x | N/A |
| 2024 | $393.94 Million | $64.25 Million | -$61.84 Million | 6.13x | N/A |
| 2025 | $106.18 Million | $71.61 Million | -$48.59 Million | 1.48x | N/A |
Competitor Companies of RCEL by Market Capitalization
Companies near Avita Medical Ltd in the global market cap rankings as of August 3, 2026.
Key companies related to Avita Medical Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Avita Medical Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Avita Medical Ltd's market cap moved from $227.75 Million to $ 135.42 Million, with a yearly change of -6.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $135.42 Million | +27.54% |
| 2025 | $106.18 Million | -73.05% |
| 2024 | $393.94 Million | -6.71% |
| 2023 | $422.26 Million | +107.88% |
| 2022 | $203.13 Million | -44.91% |
| 2021 | $368.70 Million | -35.52% |
| 2020 | $571.83 Million | -59.16% |
| 2019 | $1.40 Billion | +712.50% |
| 2018 | $172.35 Million | +4.67% |
| 2017 | $164.66 Million | -41.85% |
| 2016 | $283.15 Million | +24.32% |
| 2015 | $227.75 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Avita Medical Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $126.49 Million USD |
| MoneyControl | $126.49 Million USD |
| MarketWatch | $126.49 Million USD |
| marketcap.company | $126.49 Million USD |
| Reuters | $126.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Avita Medical Ltd
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more